Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950117-13-000213
Filing Date
2013-03-04
Accepted
2013-03-04 16:11:33
Documents
1
Period of Report
2013-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 cfp_21687.html 3  
1 FORM 3 cfp_21687.xml 3 2697
  Complete submission text file 0000950117-13-000213.txt   4186
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12864 MCCARTHY CIRCLE PHILADELPHIA PA 19154
Business Address
Kain Scott (Reporting) CIK: 0001570381 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35023 | Film No.: 13661774